Active surveillance in metastatic pancreatic neuroendocrine tumors: A 20-year single-institutional experience

BACKGROUND: Pancreatic neuroendocrine tumors (PanNETs) are heterogeneous and indolent; systemic therapy is not essential for every patient with metastatic PanNET. The National Comprehensive Cancer Network guidelines state that delaying treatment is an option for PanNET with distant metastasis, if th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, He-Li, Wang, Wen-Quan, Xu, Hua-Xiang, Wu, Chun-Tao, Li, Hao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479574/
https://www.ncbi.nlm.nih.gov/pubmed/32953851
http://dx.doi.org/10.12998/wjcc.v8.i17.3751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479574/
https://www.ncbi.nlm.nih.gov/pubmed/32953851
http://dx.doi.org/10.12998/wjcc.v8.i17.3751

Ejemplares similares